Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...
The Artificial Intelligence (AI) in Precision Medicine Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light on the market overview in its entirety touching diverse aspects like product definition, prevailing vendor landscape, and market segmentation. Through the comprehensive and...
Neurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...
The Precision Medicine market has moved from scientific concept to clinical reality over the past decade. Instead of prescribing treatments based solely on broad population averages, healthcare providers increasingly tailor therapies according to an individual’s genetic profile, environment, and lifestyle. The result? More targeted interventions, improved outcomes, and fewer...